Bezler, M., J. G. Hengstler and A. Ullrich: Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. In: Molecular Oncology 6, 5, 516-529 (2012).
Stoecklein, N. H., S. B. Hosch, M. Bezler, F. Stern, C. H. Hartmann, C. Vay, A. Siegmund, P. Scheunemann, P. Schurr, W. T. Knoefel, P. E. Verde, U. Reichelt, A. Erbersdobler, R. Grau, A. Ullrich, J. R. Izbicki and C. A. Klein: Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. In: Cancer Cell 13, 5, 441-453 (2008).
Ruhe, J. E., S. Streit, S. Hart, C. H. Wong, K. Specht, P. Knyazev, T. Knyazeva, L. S. Tay, H. L. Loo, P. Foo, W. Wong, S. Pok, S. J. Lim, H. Ong, M. Luo, H. V. Ho, K. Peng, T. C. Lee, M. Bezler, C. Mann, S. Gaertner, H. Hoefler, S. Iacobelli, S. Peter, A. Tay, S. Brenner, B. Venkatesh and A. Ullrich: Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. In: Cancer Research 67, 23, 11368-11376 (2007).
Tanner, B., D. Hasenclever, K. Stern, W. Schormann, M. Bezler, M. Hermes, M. Brulport, A. Bauer, I. B. Schiffer, S. Gebhard, M. Schmidt, E. Steiner, J. Sehouli, J. Edelmann, J. Lauter, R. Lessig, K. Krishnamurthi, A. Ullrich and J. G. Hengstler: ErbB-3 predicts survival in ovarian cancer. In: Journal of Clinical Oncology 24, 26, 4317-4323 (2006).
Cavalcanti-Adam, E. A., P. Tomakidi, M. Bezler and J. P. Spatz: The geometric organization of the extracellular matrix in the control of integrin-mediated adhesion and cell function in osteoblasts of the alveolar bone. In: Progress Orthodontics 6, 2, 232-237 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.